Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab Monotherapy vs Combination With Azathioprine in Pediatric Crohn's Disease
NCT07424040Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Mar 2026
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of azathioprine in Crohn's disease (2 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Clinical Remission Rate based on Pediatric Crohn's Disease Activity Index (PCDAI) at 54 weeks. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
azathioprine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT07424040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07424040.